Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 01, 2006 | Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $26.87 | 13,789 | |
| Feb 01, 2006 | Director, President & CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,000 | -- | 228,182 | |
| Feb 07, 2005 | VP - Operations | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $21.56 | -- | |
| Jul 18, 2018 | SVP and General Counsel | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,032 | -- | 15,032 | |
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,081 | -- | -- | |
| Jul 19, 2023 | SVP Global Operations and R&D | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,081 | -- | -- | |
| Jul 14, 2020 | SVP Global Operations and R&D | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,081 | -- | 15,081 | |
| Jul 14, 2020 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,121 | -- | 60,620 | |
| Jul 18, 2018 | SVP/GM, Global Vascular | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,126 | -- | 15,126 | |
| Oct 16, 2019 | EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,320 | -- | 15,320 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.